Global Oligonucleotide Solid Phase Synthesizer Market Growth 2024-2030

Publication ID:

LPI04240705

Publication Date:

April 16, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturers [2]

Machinery [3]

Industry & Manufacturing [4]

Description:

An Oligonucleotide Solid Phase Synthesizer is a specialized instrument used in the synthesis of oligonucleotides, which are short sequences of nucleotides (DNA or RNA). These synthesizers automate the process of assembling nucleotide sequences on a solid support, typically resin beads, in a step-by-step manner.
The global Oligonucleotide Solid Phase Synthesizer market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
publisher, Inc. (LPI) ' newest research report, the 鈥淥ligonucleotide Solid Phase Synthesizer Industry Forecast鈥� looks at past sales and reviews total world Oligonucleotide Solid Phase Synthesizer sales in 2023, providing a comprehensive analysis by region and market sector of projected Oligonucleotide Solid Phase Synthesizer sales for 2024 through 2030. With Oligonucleotide Solid Phase Synthesizer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligonucleotide Solid Phase Synthesizer industry.
This Insight Report provides a comprehensive analysis of the global Oligonucleotide Solid Phase Synthesizer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oligonucleotide Solid Phase Synthesizer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Oligonucleotide Solid Phase Synthesizer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotide Solid Phase Synthesizer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotide Solid Phase Synthesizer.
United States market for Oligonucleotide Solid Phase Synthesizer is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Oligonucleotide Solid Phase Synthesizer is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Oligonucleotide Solid Phase Synthesizer is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Oligonucleotide Solid Phase Synthesizer players cover Cytiva, BioAutomation Corporation, Biolytic Lab Performance, CSBio and Polygen GmbH, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotide Solid Phase Synthesizer market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Compact Synthesizer
Large Synthesizer
Segmentation by application
Pharmaceutical Companies
Lab
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cytiva
BioAutomation Corporation
Biolytic Lab Performance
CSBio
Polygen GmbH
Sierra BioSystems
OligoMaker
Biosearch Technologies
Key Questions Addressed in this Report
What is the 10-year outlook for the global Oligonucleotide Solid Phase Synthesizer market?
What factors are driving Oligonucleotide Solid Phase Synthesizer market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oligonucleotide Solid Phase Synthesizer market opportunities vary by end market size?
How does Oligonucleotide Solid Phase Synthesizer break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oligonucleotide Solid Phase Synthesizer Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Oligonucleotide Solid Phase Synthesizer by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Oligonucleotide Solid Phase Synthesizer by Country/Region, 2019, 2023 & 2030
2.2 Oligonucleotide Solid Phase Synthesizer Segment by Type
2.2.1 Compact Synthesizer
2.2.2 Large Synthesizer
2.3 Oligonucleotide Solid Phase Synthesizer Sales by Type
2.3.1 Global Oligonucleotide Solid Phase Synthesizer Sales Market Share by Type (2019-2024)
2.3.2 Global Oligonucleotide Solid Phase Synthesizer Revenue and Market Share by Type (2019-2024)
2.3.3 Global Oligonucleotide Solid Phase Synthesizer Sale Price by Type (2019-2024)
2.4 Oligonucleotide Solid Phase Synthesizer Segment by Application
2.4.1 Pharmaceutical Companies
2.4.2 Lab
2.5 Oligonucleotide Solid Phase Synthesizer Sales by Application
2.5.1 Global Oligonucleotide Solid Phase Synthesizer Sale Market Share by Application (2019-2024)
2.5.2 Global Oligonucleotide Solid Phase Synthesizer Revenue and Market Share by Application (2019-2024)
2.5.3 Global Oligonucleotide Solid Phase Synthesizer Sale Price by Application (2019-2024)
3 Global Oligonucleotide Solid Phase Synthesizer by Company
3.1 Global Oligonucleotide Solid Phase Synthesizer Breakdown Data by Company
3.1.1 Global Oligonucleotide Solid Phase Synthesizer Annual Sales by Company (2019-2024)
3.1.2 Global Oligonucleotide Solid Phase Synthesizer Sales Market Share by Company (2019-2024)
3.2 Global Oligonucleotide Solid Phase Synthesizer Annual Revenue by Company (2019-2024)
3.2.1 Global Oligonucleotide Solid Phase Synthesizer Revenue by Company (2019-2024)
3.2.2 Global Oligonucleotide Solid Phase Synthesizer Revenue Market Share by Company (2019-2024)
3.3 Global Oligonucleotide Solid Phase Synthesizer Sale Price by Company
3.4 Key Manufacturers Oligonucleotide Solid Phase Synthesizer Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oligonucleotide Solid Phase Synthesizer Product Location Distribution
3.4.2 Players Oligonucleotide Solid Phase Synthesizer Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oligonucleotide Solid Phase Synthesizer by Geographic Region
4.1 World Historic Oligonucleotide Solid Phase Synthesizer Market Size by Geographic Region (2019-2024)
4.1.1 Global Oligonucleotide Solid Phase Synthesizer Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Oligonucleotide Solid Phase Synthesizer Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Oligonucleotide Solid Phase Synthesizer Market Size by Country/Region (2019-2024)
4.2.1 Global Oligonucleotide Solid Phase Synthesizer Annual Sales by Country/Region (2019-2024)
4.2.2 Global Oligonucleotide Solid Phase Synthesizer Annual Revenue by Country/Region (2019-2024)
4.3 Americas Oligonucleotide Solid Phase Synthesizer Sales Growth
4.4 APAC Oligonucleotide Solid Phase Synthesizer Sales Growth
4.5 Europe Oligonucleotide Solid Phase Synthesizer Sales Growth
4.6 Middle East & Africa Oligonucleotide Solid Phase Synthesizer Sales Growth
5 Americas
5.1 Americas Oligonucleotide Solid Phase Synthesizer Sales by Country
5.1.1 Americas Oligonucleotide Solid Phase Synthesizer Sales by Country (2019-2024)
5.1.2 Americas Oligonucleotide Solid Phase Synthesizer Revenue by Country (2019-2024)
5.2 Americas Oligonucleotide Solid Phase Synthesizer Sales by Type
5.3 Americas Oligonucleotide Solid Phase Synthesizer Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oligonucleotide Solid Phase Synthesizer Sales by Region
6.1.1 APAC Oligonucleotide Solid Phase Synthesizer Sales by Region (2019-2024)
6.1.2 APAC Oligonucleotide Solid Phase Synthesizer Revenue by Region (2019-2024)
6.2 APAC Oligonucleotide Solid Phase Synthesizer Sales by Type
6.3 APAC Oligonucleotide Solid Phase Synthesizer Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oligonucleotide Solid Phase Synthesizer by Country
7.1.1 Europe Oligonucleotide Solid Phase Synthesizer Sales by Country (2019-2024)
7.1.2 Europe Oligonucleotide Solid Phase Synthesizer Revenue by Country (2019-2024)
7.2 Europe Oligonucleotide Solid Phase Synthesizer Sales by Type
7.3 Europe Oligonucleotide Solid Phase Synthesizer Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oligonucleotide Solid Phase Synthesizer by Country
8.1.1 Middle East & Africa Oligonucleotide Solid Phase Synthesizer Sales by Country (2019-2024)
8.1.2 Middle East & Africa Oligonucleotide Solid Phase Synthesizer Revenue by Country (2019-2024)
8.2 Middle East & Africa Oligonucleotide Solid Phase Synthesizer Sales by Type
8.3 Middle East & Africa Oligonucleotide Solid Phase Synthesizer Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oligonucleotide Solid Phase Synthesizer
10.3 Manufacturing Process Analysis of Oligonucleotide Solid Phase Synthesizer
10.4 Industry Chain Structure of Oligonucleotide Solid Phase Synthesizer
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oligonucleotide Solid Phase Synthesizer Distributors
11.3 Oligonucleotide Solid Phase Synthesizer Customer
12 World Forecast Review for Oligonucleotide Solid Phase Synthesizer by Geographic Region
12.1 Global Oligonucleotide Solid Phase Synthesizer Market Size Forecast by Region
12.1.1 Global Oligonucleotide Solid Phase Synthesizer Forecast by Region (2025-2030)
12.1.2 Global Oligonucleotide Solid Phase Synthesizer Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oligonucleotide Solid Phase Synthesizer Forecast by Type
12.7 Global Oligonucleotide Solid Phase Synthesizer Forecast by Application
13 Key Players Analysis
13.1 Cytiva
13.1.1 Cytiva Company Information
13.1.2 Cytiva Oligonucleotide Solid Phase Synthesizer Product Portfolios and Specifications
13.1.3 Cytiva Oligonucleotide Solid Phase Synthesizer Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Cytiva Main Business Overview
13.1.5 Cytiva Latest Developments
13.2 BioAutomation Corporation
13.2.1 BioAutomation Corporation Company Information
13.2.2 BioAutomation Corporation Oligonucleotide Solid Phase Synthesizer Product Portfolios and Specifications
13.2.3 BioAutomation Corporation Oligonucleotide Solid Phase Synthesizer Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 BioAutomation Corporation Main Business Overview
13.2.5 BioAutomation Corporation Latest Developments
13.3 Biolytic Lab Performance
13.3.1 Biolytic Lab Performance Company Information
13.3.2 Biolytic Lab Performance Oligonucleotide Solid Phase Synthesizer Product Portfolios and Specifications
13.3.3 Biolytic Lab Performance Oligonucleotide Solid Phase Synthesizer Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Biolytic Lab Performance Main Business Overview
13.3.5 Biolytic Lab Performance Latest Developments
13.4 CSBio
13.4.1 CSBio Company Information
13.4.2 CSBio Oligonucleotide Solid Phase Synthesizer Product Portfolios and Specifications
13.4.3 CSBio Oligonucleotide Solid Phase Synthesizer Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 CSBio Main Business Overview
13.4.5 CSBio Latest Developments
13.5 Polygen GmbH
13.5.1 Polygen GmbH Company Information
13.5.2 Polygen GmbH Oligonucleotide Solid Phase Synthesizer Product Portfolios and Specifications
13.5.3 Polygen GmbH Oligonucleotide Solid Phase Synthesizer Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Polygen GmbH Main Business Overview
13.5.5 Polygen GmbH Latest Developments
13.6 Sierra BioSystems
13.6.1 Sierra BioSystems Company Information
13.6.2 Sierra BioSystems Oligonucleotide Solid Phase Synthesizer Product Portfolios and Specifications
13.6.3 Sierra BioSystems Oligonucleotide Solid Phase Synthesizer Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Sierra BioSystems Main Business Overview
13.6.5 Sierra BioSystems Latest Developments
13.7 OligoMaker
13.7.1 OligoMaker Company Information
13.7.2 OligoMaker Oligonucleotide Solid Phase Synthesizer Product Portfolios and Specifications
13.7.3 OligoMaker Oligonucleotide Solid Phase Synthesizer Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 OligoMaker Main Business Overview
13.7.5 OligoMaker Latest Developments
13.8 Biosearch Technologies
13.8.1 Biosearch Technologies Company Information
13.8.2 Biosearch Technologies Oligonucleotide Solid Phase Synthesizer Product Portfolios and Specifications
13.8.3 Biosearch Technologies Oligonucleotide Solid Phase Synthesizer Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Biosearch Technologies Main Business Overview
13.8.5 Biosearch Technologies Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂